About 700 reports

  • NOVARTIS - QVM149
  • NOVARTIS - FEVIPIPRANT

This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The...

  • Cancer
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Antibody therapeutics in late-stage clinical studies for non-cancer indications.

Top ## players hold majority of stake in the market ##.

  • Cancer
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.

The protein is released from cells in the body during an asthma attack and triggers an inflammatory response.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Social Conditions

Gilead Sciences Disrupts HCV Market Figure ##-##: Gilead Sciences Dominates HCV Market, Displaces Current Therapies ($ millions) Bristol-Myers Squibb - Opdivo Disrupts Monoclonal Antibody Performance in Cancer Figure ##-##: Monoclonal Antibodies in Cancer Treatment, Opdivo

  • Cancer
  • Leukemia
  • Oncology
  • World
  • Market Size
  • ASTHMA
  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest...

  • Cancer
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC

SEGMENTATION ##.

  • Cancer
  • United States
  • Amgen Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Cancer
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.

Drug Analysis: Masitinib Product Profiles masitinib : Prostate cancer masitinib : Colorectal cancer (CRC) masitinib : Asthma masitinib : Pancreatic cancer LIST OF FIGURES Figure ##: Masitinib for prostate cancer – SWOT analysis Figure ##: Datamonitor Healthcare’s drug assessment sum

  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • European Union
  • United States

Drug Overview: Masitinib TABLE OF CONTENTS ## Product Profiles## masitinib : Prostate cancer ## masitinib : Colorectal cancer (CRC) ## masitinib : Asthma ## masitinib : Pancreatic cancer LIST OF FIGURES ## Figure ##: Masitinib for prostate cancer – SWOT analysis ## Figure ##: Datamon

  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • European Union
  • United States

ATOPY, OR ALLERGY, IS INDICATED BY A PERSONAL AND SOMETIMES FAMILY HISTORY OF ASTHMA, ALLERGIC RHINITIS, OR THE MOST COMMONLY SEEN MANIFESTATION, ECZEMATOUS DERMATITIS.

  • Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Leukotriens drive inflammation and are known to cause asthma.

  • Cancer
  • Sweden
  • Janssen Biotech, Inc.
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

You can easily book an appointment with one online.

  • Cancer
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA
  • OPKO Health, Inc.
  • 4 NUCLEAR MEDICINE GLOBAL MARKET, BY MODALITY

Tc-##mhexamethyl propylene amine oxime (HMPAO) SPECT/ CT lung scans are used for asthma patients in studying the pathophysiological functions of lungs.

  • Cancer
  • World
  • Market Size
  • Cardinal Health, Inc.
  • Lantheus Medical Imaging, Inc.
  • 8.1 REFERENCES

PLoS One; ##(##): e## Kotsopoulos J, et al. (2010).

  • Cancer
  • World
  • AbbVie Inc.
  • Aduro BioTech, Inc.
  • Amgen Inc.

ONE; ##(##): ##-##.

  • Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Other Companies ##.

  • Cancer
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • PIPELINE PORTFOLIO

AMONG THESE, COPD AND ASTHMA ARE THE MOST PREVALENT WORLDWIDE.

  • Cancer
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.
  • Pipeline portfolio

Opdivo Binds to PD-## on T and NKT cells.

  • Cancer
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

The auto exports exceeded over ## million each year.

  • Cancer
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

They produce medicines that treat six major disease areas ---- asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Demand
  • Supply
  • Novartis AG

The following section examines trends in co-development and licensing strategic consolidations in the market for asthma between 2006 and 2017.

  • Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

GSK produces medicines that treat six major disease areas----asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • Ltd Shanghai Richem International Co.

Risks of serious side effects, including asthma, appendicitis and autoimmune diseases have been reported, as have allergic reactions to specific antigens, although these have been rare.

  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • Molecule name Molecule type
  • IMMUNOTHERAPEUTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy. The global immunotherapeutics market is divided based on the segments,...

  • Cancer
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

ABOUT ## IN ##, ## PEOPLE WHO GET MEASLES WILL DIE.

  • Cancer
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.
  • Pipeline portfolio

Opdivo Binds to PD-## on T and NKT cells.

  • Cancer
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • 7.3. FORECAST METHODOLOGY
  • depicts the distribution of the pipeline by the type of therapy. Nearly 80% of the

THE DRUG IS CURRENTLY BEING DEVELOPED IN PHASE III FOR ASTHMA AND COPD.

  • Cancer
  • North America
  • United States
  • MedImmune, LLC
  • Roche Group

This agreement allows AstraZeneca to concentrate the efforts in Respiratory as one of the three strategic therapy areas, on transforming the treatment of asthma and COPD, where budesonide remains a key component of the company' s marketed as well as pipeline medicines.

  • Cancer
  • World
  • AbbVie Inc.
  • AstraZeneca PLC
  • Clovis Oncology, Inc.

GSK produces medicines that treat six major disease areas----asthma, virus control, infections, mental health, diabetes and digestive conditions.

  • Cancer
  • China
  • Eli Lilly & Co.
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd